Pharmacologic therapy for type 2 diabetes mellitus

RA DeFronzo - Annals of internal medicine, 1999 - acpjournals.org
Type 2 diabetes mellitus is a chronic metabolic disorder that results from defects in both
insulin secretion and insulin action. An elevated rate of basal hepatic glucose production in …

ATP-sensitive and inwardly rectifying potassium channels in smooth muscle

JM Quayle, MT Nelson… - Physiological reviews, 1997 - journals.physiology.org
The properties and roles of ATP-sensitive (KATP) and inwardly rectifying (KIR) potassium
channels are reviewed. Potassium channels regulate the membrane potential of smooth …

Antihyperglycemic effects of stevioside in type 2 diabetic subjects

S Gregersen, PB Jeppesen, JJ Holst, K Hermansen - Metabolism, 2004 - Elsevier
Stevioside is present in the plant Stevia rebaudiana Bertoni (SrB). Extracts of SrB have been
used for the treatment of diabetes in, for example, Brazil, although a positive effect on …

Diastolic dysfunction in normotensive men well-controlled type 2 diabetes

P Poirier, P Bogaty, C Garneau, L Marois… - Clinical …, 2001 - journals.viamedica.pl
OBJECTIVE. Because a pseudonormal pattern of ventricular filling has never been
considered in studies that reported a prevalence of left ventricular diastolic dysfunction …

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

DT Eurich, SR Majumdar, FA McAlister… - Diabetes …, 2005 - Am Diabetes Assoc
OBJECTIVE—Metformin is considered contraindicated in patients with heart failure because
of concerns over lactic acidosis, despite increasing evidence of potential benefit. The aim of …

Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment

RJ Mahler, ML Adler - The Journal of Clinical Endocrinology & …, 1999 - academic.oup.com
SIXTEEN million individuals in the United States with type 2 diabetes mellitus and an
additional 30–40 million with impaired glucose tolerance result in health care costs …

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment

H Ilkova, B Glaser, A Tunçkale, N Bagriaçik… - Diabetes …, 1997 - Am Diabetes Assoc
OBJECTIVE Type 2 diabetes is a slowly progressive disease, in which the gradual
deterioration of glucose tolerance is associated with the progressive decrease in β-cell …

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

JA Johnson, SR Majumdar, SH Simpson… - Diabetes …, 2002 - Am Diabetes Assoc
OBJECTIVE—The aim of this study was to examine the relationship between use of
metformin and sulfonylurea and mortality in new users of these agents. RESEARCH …

ATP-sensitive K+ channels and insulin secretion: their role in health and disease

FM Ashcroft, FM Gribble - Diabetologia, 1999 - search.proquest.com
Sulphonylureas have been used for over 50 years to enhance insulin secretion in patients
with Type II (non-insulin-dependent) diabetes mellitus but their therapeutic target was not …

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

JMM Evans, SA Ogston, A Emslie-Smith, AD Morris - Diabetologia, 2006 - Springer
Aims/hypothesis The aim of this study was to evaluate the risk of adverse cardiovascular
outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin …